Get started
Author

Shuihong Yu

Observed name: Yu, Shuihong
Observed institution: Anqing Medical College
ORCID: 0000-0001-7842-037X
Observed ORCID: 0000-0001-7842-037X
OpenAlex ID: A5113367285
Discovery of novel NLRP3 inhibitors based on machine learning and physical methods
2024 · Tao Jiang, Shijing Qian, et al. · BMC Chemistry · 4
PDF
Dual Roles of EZH2 in Tumor Proliferation and Immune Evasion in Lung Squamous Cell Carcinoma: A Pathway to Novel Immunotherapeutic Approaches
2025 · Ling Xu, Chun Ye, et al. · Journal of Immunotherapy · 3
Discovering potential WRN inhibitors from natural product database through computational methods
2024 · Tao Jiang, Yunfeng Zhang, et al. · Journal of Molecular Graphics and Modelling · 3
Role of uridine phosphorylase 1 in cancer: A comprehensive pan-cancer analysis highlighting its prognostic and therapeutic potential
2026 · Shuihong Yu, Tao Jiang · Medicine · 2
Network Pharmacology, Molecular Docking, Molecular Dynamics Simulation, and in vitro Experiments to Explore the Mechanism of Asiatic Acid Inhibiting Acetaldehyde-Induced Activation of Hepatic Stellate Cells
2023 · Tao Jiang, Xiaojin Chen, et al. · Natural Product Communications · 1
PDF
Phosphorylated protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) expression in breast cancer is correlated with malignant proliferation and histological grading.
2025 · Xiaosi Yang, Shuqiang Duan, et al. · PubMed
Exploring the Effect of Corydalis Yanhusuo on Hepatoc ellular Carcinoma Mechanism through Network Pharma cology,Molecular docking and In Vitro Experiments
2023 · Shuihong Yu, Huijuan Liu, et al. · Research Square
PDF
Works count: 9
Citation count: 13
H-index: 3
I10-index:
Year
Topic
Type